Panvel stock carries BRL 2.2 billion market cap after BTG lifts outlook
Published on 10/07/2026 at 04:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSPanvel stock (ISIN BRPNVLACNOR9) carried a market capitalization of BRL 2.2 billion on October 7, 2026, with a 52-week range of BRL 9.01 to BRL 16.57. The main company-specific driver remains the earnings outlook after Panvel's second-quarter 2026 results.
BTG raises profit expectations
According to Eu Quero Investir on September 22, 2026, BTG Pactual raised its adjusted net income forecast for 2026 from BRL 176 million to BRL 185 million and kept a BRL 19 price target. The report followed second-quarter results that exceeded the bank's estimates.
The revised forecast gives the market a clearer operating benchmark: BTG projects 2026 net revenue of BRL 6.334 billion, EBITDA of BRL 400 million and an EBITDA margin of 5.9 percent. The bank also lifted its net income projections for the following three years by 11 percent, according to the same September 22 report.
GLP-1 growth meets margin pressure
BTG Pactual reported on September 22, 2026, that Panvel's GLP-1 revenue increased 91 percent in the first half of 2026 by the bank's estimate. In the second quarter, the category generated BRL 184 million, equal to 11.3 percent of sales.
The growth mix also creates a counterweight. BTG said gross margin fell 30 basis points in the first half of 2026 because GLP-1 products carry lower margins, while adjusted EBITDA margin before IFRS 16 improved by 40 basis points through selling, general and administrative cost dilution.
Expansion remains the execution test
Panvel opened 12 stores in the first half of 2026, while its long-term plan targets 950 to 1,000 stores by 2030. BTG expects a 5.9 percent EBITDA margin in 2026 and 6.5 percent by 2030, which remains 20 basis points below the lower end of Panvel's long-term margin target.
The company operates in pharmacy retail and has its largest footprint in southern Brazil. The key investor question is therefore operational rather than purely demand-driven: whether GLP-1 growth and cost dilution can offset lower category margins while store openings accelerate.
Panvel stock keeps a wide yearly range
Panvel stock had a BRL 2.2 billion market capitalization and a BRL 9.01 to BRL 16.57 52-week range as of October 7, 2026. The figures frame the BRL 19 BTG target against a company whose next phase depends on margin delivery and network expansion.
Panvel stock key facts
- Company: Dimed S.A. Distribuidora de Medicamentos
- ISIN: BRPNVLACNOR9
- Ticker: PNVL3
- Trading venue: B3
- Market capitalization: BRL 2.2 billion (as of October 7, 2026)
- 52-week range: BRL 9.01-16.57 (as of October 7, 2026)
- Sector / Industry: Health care / Pharmacy retail
- Index membership: ICON, SMLL
